FDA Inspection
Pinnacle Transplant Technologies, LLCPinnacle Transplant Technologies, LLC – FDA Inspection, Aug 29, 2022
Record Details
This FDA Inspection record concerns Pinnacle Transplant Technologies, LLC, with an inspection on August 29, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- August 29, 2022
- Product Type
- Biologics
View Company Profile
ID · 8028ad29-9d34-496f-8edb-71d2db9b7ac8
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1178426
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Enforcement
- Warning Letter
Other FDA inspections of Pinnacle Transplant Technologies, LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 28, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 9, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 16, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 25, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Pinnacle Transplant Technologies, LLC
- FDA Inspection 1119254 - 2020-02-28
- FDA Inspection 1029102 - 2017-08-09
- FDA Inspection 891843 - 2014-07-16
- FDA Inspection 768806 - 2012-02-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.